RedHill Biopharma (RDHL) EBITDA Margin Growth (3y) (2015 - 2023)
RedHill Biopharma (RDHL) EBITDA Margin Growth (3y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,673.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -37.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,395.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,442.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,299.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5,091.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5,193.00 |
| 10 | RedHill Biopharma | 640,064.98 | 640,064.98 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 293,306.00 |
| Mar 31, 2023 | -241,937.00 |
| Dec 31, 2022 | -133,169.00 |
| Sep 30, 2022 | -66,214.00 |
| Jun 30, 2022 | -74,214.00 |
| Mar 31, 2022 | -40,350.00 |
| Dec 31, 2021 | -138,043.00 |
| Sep 30, 2021 | -36,083.00 |
| Jun 30, 2021 | -29,094.00 |
| Mar 31, 2021 | -32,057.00 |
| Dec 31, 2020 | -62,611.00 |
| Sep 30, 2020 | -84,790.00 |
| Jun 30, 2020 | -274,329.00 |
| Mar 31, 2020 | 20.37 Mn |
| Jun 30, 2019 | -71.86 Mn |
| Dec 31, 2018 | -892,529.00 |
| Jun 30, 2018 | -58.86 Mn |
| Mar 31, 2018 | -47.51 Mn |
| Dec 31, 2017 | -48.07 Mn |
| Sep 30, 2017 | 91,681.00 |